EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) has received a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, two have given a hold rating, three have assigned a buy rating and two have given a strong buy rating to the company.
A number of equities research analysts have issued reports on ESLOY shares. Zacks Research raised shares of EssilorLuxottica from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 18th. Kepler Capital Markets downgraded shares of EssilorLuxottica from a “strong-buy” rating to a “strong sell” rating in a research note on Thursday, September 17th. The Goldman Sachs Group lowered EssilorLuxottica from a “buy” rating to a “hold” rating in a report on Tuesday, July 14th. Deutsche Bank Aktiengesellschaft raised EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Thursday, October 22nd. Finally, Citigroup restated a “buy” rating on shares of EssilorLuxottica in a research note on Monday, October 19th.
Check Out Our Latest Stock Analysis on EssilorLuxottica
EssilorLuxottica Trading Up 2.2%
Shares of EssilorLuxottica stock opened at $104.93 on Tuesday. EssilorLuxottica has a 12 month low of $79.27 and a 12 month high of $186.81. The company has a quick ratio of 0.59, a current ratio of 0.89 and a debt-to-equity ratio of 0.17. The business has a fifty day simple moving average of $88.06 and a 200-day simple moving average of $107.79.
About EssilorLuxottica
EssilorLuxottica is a global company specializing in the design, manufacture and distribution of ophthalmic lenses, eyewear and related optical products. Its activities span the value chain, including lens technology, prescription frames, sunglasses, retail, wholesale distribution and vision-care services.
The company’s portfolio includes well-known eyewear brands such as Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear and Costa. Its lens and vision-care brands include Varilux, Crizal, Transitions and Eyezen.
Read More
- Five stocks we like better than EssilorLuxottica
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
